Trials / Completed
CompletedNCT02039128
KOmparison Study KOmparison Study
A Double-blind, Randomized, Placebo-controlled Study to Assess Changes in the Omega-3 Index in Erythrocytes After Twelve Weeks of Daily Intake of SuperbaTM Krill Oil or Fish Oil
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Aker BioMarine Human Ingredients AS · Industry
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
In this double blind, placebo controlled, parallel group study, the relative uptake of 1g/d krill oil in comparison to 1g/d fish oil in healthy female and male adults will be assessed. Primary objective is to determine if a 12 week supplementation with krill oil increases tissue levels in erythrocytes (omega-3 index) significantly more than fish oil after dose adjustments to EPA and DHA levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Krill oil or Fish oil | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2014-01-17
- Last updated
- 2014-07-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02039128. Inclusion in this directory is not an endorsement.